Brief: Vitura Health Says Cortexa Advances Commercialisation Of MDMA Supply In Australia
23/03/2026 24:56
March 23 (Reuters) - Vitura Health Ltd VIT.AX: CORTEXA ADVANCES COMMERCIALISATION OF MDMA SUPPLY IN AUSTRALIA Further company coverage: VIT.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vitura Health
See all newsAustralia's Vitura Health gains on quarterly profit jump
Australia's Vitura Health hits record low on FY27 revenue warning
Brief: Vitura Health Says Bupa To Redirect All International-Member Telehealth Referrals
Australia's Vitura Health slips after company flags FY27 revenue impact
Brief: Vitura Health Appoints Tom Howitt As Interim CFO Effective Immediately